Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran

被引:18
|
作者
Molla, Ghasem Janbabaei [1 ]
Ismail-Beigi, Faramarz [2 ]
Larijani, Bagher [3 ]
Khaloo, Pegah [4 ]
Moosaie, Fatemeh [4 ]
Alemi, Hamid [4 ]
Mansournia, Mohammad Ali [5 ]
Ghadimi, Tayyeb [6 ]
Ghaemi, Fatemeh [7 ]
Nakhjavani, Manouchehr [4 ]
Esteghamati, Alireza [4 ]
机构
[1] Minist Hlth & Med Educ, Curat Affairs, Tehran, Iran
[2] Case Western Reserve Univ, Dept Med Biochem Physiol & Biophys, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA
[3] Univ Tehran Med Sci, Diabet Researcher Ctr, Endocrinol & Metab Res Inst, Tehran, Iran
[4] Univ Tehran Med Sci, Vali Asr Hosp, Endocrinol & Metab Res Ctr, Sch Med, Tehran, Iran
[5] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[6] Iran Med Univ, Dept Surg, Tehran, Iran
[7] Minist Hlth & Med Educ, Dept Transplantat & Dis, Tehran, Iran
关键词
cardiovascular diseases (CVD); diabetes complications; diabetes nephropathies; diabetes retinopathy; glycemic/lipid control; smoking; CIGARETTE-SMOKING; RISK-FACTORS; PROGRESSION; NEUROPATHY; MORTALITY; MELLITUS; DISEASE;
D O I
10.1016/j.jcjd.2019.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Smoking is among the top leading causes of morbidity and mortality worldwide. To date, studies on the association between smoking and diabetes complications and metabolic control have shown conflicting results. In this study, we aimed to assess the association of smoking with micro- and macrovascular complications of diabetes and lipid and glycemic indices. Methods: We used the National Program for Prevention and Control of Diabetes of Iran database of 99,651 adult patients with diabetes across Iran. Multiple logistic regression models were used to examine the association between smoking and diabetes complications including cardiovascular disease, neuropathy, nephropathy and retinopathy. This association was adjusted for age, sex, duration of diabetes, glycated hemoglobin (A1C), hypertension, hyperlipidemia, medication, obesity and type of diabetes. Results: Smoking was associated with cardiovascular disease, nephropathy, retinopathy and neuropathy (odds ratios [ORs1 for patients with type 1 diabetes were 1.51, 2.29, 2.70 and 2.40, respectively; for patients with type 2 diabetes, ORs were 1.27, 1.21, 1.51 and 1.70, respectively; all with p values <0.001). Among patients with type 1 diabetes, smoking was significantly (p<0.05) associated with A1C (OR, 2.12), 2-h postglucose level (OR, 1.30), triglycerides (OR, 1.48) and high-density lipoprotein (HDL) control (OR, 1.34). Among patients with type 2 diabetes, smoking was significantly associated with A1C (OR, 1.09) and HDL control (OR, 1.21). Conclusions: Smoking was associated with multiple diabetes complications including cardiovascular disease, neuropathy, nephropathy and retinopathy and worse A1C and HDL control in both patients with type 1 and type 2 diabetes. It was also associated with worse 2-h postglucose level and triglyceride control among patients with type 1 diabetes. Our findings signify that national programs for smoking prevention and cessation may be beneficial to diabetes control in Iran. (C) 2019 Canadian Diabetes Association.
引用
收藏
页码:246 / 252
页数:7
相关论文
共 50 条
  • [11] Ottawa charter framework as a guide for type 2 diabetes prevention and control in Iran
    Maryam Peimani
    Ensieh Nasli-Esfahani
    Elham Shakibazadeh
    Journal of Diabetes & Metabolic Disorders, 2019, 18 : 255 - 261
  • [12] Ottawa charter framework as a guide for type 2 diabetes prevention and control in Iran
    Peimani, Maryam
    Nasli-Esfahani, Ensieh
    Shakibazadeh, Elham
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2019, 18 (01) : 255 - 261
  • [13] Weight Loss among Adults with Type 2 Diabetes Participating in the Diabetes Prevention Program
    Carpenedo, Dorota
    Brokaw, Sarah M.
    Tysk, Sonja
    Fernandes, Jessie
    Helgerson, Steven D.
    Harwell, Todd S.
    DIABETES, 2018, 67
  • [14] Barriers to glycemic control in youth with type 1 diabetes and type 2 diabetes
    Anderson, Barbara J.
    McKay, Siripoom V.
    PEDIATRIC DIABETES, 2011, 12 (03) : 197 - 205
  • [16] Autoimmunity and prevention of type 2 diabetes: the Diabetes Prevention Program (DPP)
    Dabelea, D.
    Ma, Y.
    Knowler, W. C.
    Marcovina, S.
    Saudek, C.
    Arakaki, R.
    White, N. H.
    Kahn, S.
    Haffner, S. M.
    Orchard, T.
    Goldberg, R.
    Hamman, R. F.
    DIABETOLOGIA, 2006, 49 : 192 - 192
  • [17] Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond
    Gruss, Stephanie M.
    Nhim, Kunthea
    Gregg, Edward
    Bell, Miriam
    Luman, Elizabeth
    Albright, Ann
    CURRENT DIABETES REPORTS, 2019, 19 (09)
  • [18] Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond
    Stephanie M. Gruss
    Kunthea Nhim
    Edward Gregg
    Miriam Bell
    Elizabeth Luman
    Ann Albright
    Current Diabetes Reports, 2019, 19
  • [19] Glycaemic control and diabetes care utilization in young adults with Type 1 diabetes
    Sparud-Lundin, C.
    Ohrn, I.
    Danielson, E.
    Forsander, G.
    DIABETIC MEDICINE, 2008, 25 (08) : 968 - 973